NDC 65162-778 – Budesonide
Budesonide 3 mg/1 · Capsule, Delayed Release · Oral
Product NDC65162-778
Product details
- Brand name
- Budesonide
- Generic name
- Budesonide
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- Capsule, Delayed Release
- Route
- Oral
- Marketing category
- ANDA · ANDA206200
- Marketed since
- September 15, 2017
- Listing expires
- December 31, 2026
- Pharmacologic class
- Corticosteroid
Active ingredients
- Budesonide 3 mg/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 65162-778-10 | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65162-778-10) | Sep 15, 2017 |
| 65162-778-18 | 180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65162-778-18) | Sep 15, 2017 |
| 65162-778-30 | 300 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65162-778-30) | Sep 15, 2017 |
| 65162-778-49 | 21 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65162-778-49) | Sep 15, 2017 |
Other budesonide products
- 50090-6586 Budesonide .5 mg/2mL · Suspension · A-S Medication Solutions
- 50090-1467 Budesonide .25 mg/2mL · Suspension · A-S Medication Solutions
- 50090-6590 Budesonide .25 mg/2mL · Suspension · A-S Medication Solutions
- 50090-7173 Budesonide .25 mg/2mL · Inhalant · A-S Medication Solutions
- 0591-2510 Budesonide 9 mg/1 · Tablet, Film Coated, Extended Release · Actavis Pharma, Inc.
- 60687-596 Budesonide 3 mg/1 · Capsule, Coated Pellets · American Health Packaging
- 60687-889 Budesonide .25 mg/2mL · Suspension · American Health Packaging
- 53746-778 Budesonide 3 mg/1 · Capsule, Delayed Release · Amneal Pharmaceuticals of New York LLC
- 60505-6129 Budesonide 32 ug/1 · Spray, Metered · Apotex Corp.
- 59651-585 Budesonide .5 mg/2mL · Suspension · Aurobindo Pharma Limited
- 63629-8294 Budesonide 3 mg/1 · Capsule, Delayed Release · Bryant Ranch Prepack
- 72162-2473 Budesonide 3 mg/1 · Capsule · Bryant Ranch Prepack